VIVO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VIVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Meridian Bioscience's long-term debt to total assests ratio for the quarter that ended in Sep. 2022 was 0.06.
Meridian Bioscience's long-term debt to total assets ratio declined from Sep. 2021 (0.14) to Sep. 2022 (0.06). It may suggest that Meridian Bioscience is progressively becoming less dependent on debt to grow their business.
The historical data trend for Meridian Bioscience's LT-Debt-to-Total-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meridian Bioscience Annual Data | |||||||||||||||||||||
Trend | Sep13 | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | |||||||||||
LT-Debt-to-Total-Asset | Get a 7-Day Free Trial | 0.18 | 0.23 | 0.18 | 0.14 | 0.06 |
Meridian Bioscience Quarterly Data | ||||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
LT-Debt-to-Total-Asset | Get a 7-Day Free Trial | 0.14 | 0.12 | 0.07 | 0.06 | 0.06 |
Meridian Bioscience's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2022 is calculated as
LT Debt to Total Assets (A: Sep. 2022 ) | = | Long-Term Debt & Capital Lease Obligation (A: Sep. 2022 ) | / | Total Assets (A: Sep. 2022 ) |
= | 29.127 | / | 463.097 | |
= | 0.06 |
Meridian Bioscience's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2022 is calculated as
LT Debt to Total Assets (Q: Sep. 2022 ) | = | Long-Term Debt & Capital Lease Obligation (Q: Sep. 2022 ) | / | Total Assets (Q: Sep. 2022 ) |
= | 29.127 | / | 463.097 | |
= | 0.06 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meridian Bioscience (NAS:VIVO) LT-Debt-to-Total-Asset Explanation
LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.
Thank you for viewing the detailed overview of Meridian Bioscience's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Julie Diana Smith | officer: Sr VP, Controller, PAO | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
John P. Kenny | director, officer: Chief Executive Officer | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Andrew S. Kitzmiller | officer: EVP & CFO | ONE BATESVILLE BLVD., BATESVILLE IN 47006 |
Bryan T Baldasare | officer: Interim CFO & Chief Acctg Off | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Rice John Mccune Jr. | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Bihl Anthony P Iii | director | 807 SMITH RIDGE ROAD, NEW CANAAN CT 06840 |
Tony Serafini-lamanna | officer: Executive VP-Diagnostics | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Felicia Williams | director | C/O MACY'S, INC., 151 WEST 34TH STREET, NEW YORK NY 10001 |
John Mcilwraith | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
David Phillips | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
James M. Anderson | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Dwight E Ellingwood | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Lawrence Baldini | officer: Exec VP, Operations & IS | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Eric S. Rasmussen | officer: EVP, Bus. Development/Strategy | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Lourdes Weltzien | officer: EVP, Life Science | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
From GuruFocus
By PRNewswire PRNewswire • 07-02-2022
By PRNewswire PRNewswire • 07-05-2022
By PRNewswire PRNewswire • 07-07-2022
By PRNewswire PRNewswire • 06-16-2022
By PRNewswire PRNewswire • 07-15-2022
By PRNewswire PRNewswire • 07-29-2022
By PRNewswire PRNewswire • 07-06-2022
By PRNewswire PRNewswire • 07-28-2022
By PRNewswire PRNewswire • 06-26-2022
By PRNewswire PRNewswire • 06-22-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.